Vaccine Technologies Market, By Technology, By Disease Indication, By Route of Administration, By Age Group, By Distribution Channel, By Geography

Description

The global vaccine technologies market size is estimated to be valued at US$ 45.40 Bn in 2023 and is expected to reach US$ 91.50 Bn by 2030, growing at a compound annual growth rate (CAGR) of 10.5% from 2023 to 2030

Report Coverage		Report Details
Base Year:	2022	Market Size in 2023:	US$ 45.40 Bn
Historical Data for:	2018 to 2021	Forecast Period:	2023 - 2030
Forecast Period 2023 to 2030 CAGR:	10.50%	2030 Value Projection:	US$ 91.50 Bn

Figure 1. Global Vaccine Technologies Market Share (%), By Region, 2023

Vaccine technology refers to the methods and strategies used to create vaccines. Vaccines are biological substances that can improve immunity to a particular disease. They prepare the body's immune system to fight off specific infections. Vaccine technologies have witnessed remarkable advancements, revolutionizing disease prevention. These innovative methods utilize various approaches such as mRNA, viral vector, protein subunit, and DNA-based platforms. Unlike traditional vaccines, these cutting-edge technologies enable rapid development and adaption to emerging pathogens. By stimulating the immune system to recognize and combat specific diseases, these vaccines offer promising avenues to tackle global health challenges more effectively. As a result, the landscape of immunization has evolved, ushering in a new era of proactive and precise disease control. Vaccine technologies includes live-attenuated vaccines, inactivated vaccines, subunit vaccines, toxoid vaccines, viral vector vaccines, messenger rna (mrna) vaccines.

Market Dynamics:

Increasing product approval by the regulatory authorities is expected to drive the growth of the global vaccine technologies market over the forecast period. For instance, in December 2022, Takeda Pharmaceutical Company Limited, a multinational pharmaceutical company, announced that the European Commission (EC) had granted marketing authorization for the company's dengue vaccine QDENGA (Dengue Tetravalent Vaccine [Live, Attenuated]) (TAK-003) for the prevention of dengue disease in individuals from four years of age in the European Union (EU). Moreover, in June 2021, CanSinoBIO, a biopharmaceutical company, announced that the National Medical Products Administration (NMPA) of China granted approval for its Group C and Group A Meningococcal Conjugate Vaccine which has the trade name Menphecia. Menphecia delivers protection against infection with Group A and C Neisseria meningitides.

Key features of the study:

This report provides an in-depth analysis of the global vaccine technologies market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the vaccine technologies market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Pfizer-BioNTech, Moderna, Johnson & Johnson, AstraZeneca, Sanofi, Novavax, GSK, Sinovac Biotech, Bharat Biotech, Emergent BioSolutions, Dynavax Technologies, CureVac, Valneva, and Takeda Pharmaceutical Company Limited.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global vaccine technologies market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the vaccine technologies market

Detailed Segmentation:

Global Vaccine Technologies Market Segmentation, By Technology:
- Live-attenuated vaccines
- Inactivated vaccines
- Subunit vaccines
- Toxoid vaccines
- Viral vector vaccines
- Messenger RNA (mRNA) vaccines
Global Vaccine Technologies Market Segmentation, By Disease Indication:
- Infectious Diseases
- Non-Infectious Diseases
Global Vaccine Technologies Market Segmentation, By Route of Administration:
- Parenteral
- Oral
- Nasal
Global Vaccine Technologies Market Segmentation, By Age Group:
- Pediatric
- Adult
Global Vaccine Technologies Market Segmentation, By Distribution Channel:
- Public Sector
- Private Sector
Global Vaccine Technologies Market Segmentation, By Geography:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profile:
- Pfizer-BioNTech
- Moderna
- Johnson & Johnson
- AstraZeneca
- Sanofi
- Novavax
- GSK
- Sinovac Biotech
- Bharat Biotech
- Emergent BioSolutions
- Dynavax Technologies
- CureVac
- Valneva
- Takeda Pharmaceutical Company Limited

Product Code: CMI6150

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Vaccine Technologies, By Technology
- Market Vaccine Technologies, By Disease Indication
- Market Vaccine Technologies, By Route of Administration
- Market Vaccine Technologies, By Age Group
- Market Vaccine Technologies, By Distribution Channel
- Market Vaccine Technologies, By Geography
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
Global Health Concerns and Pandemics
- Restraints
Regulatory Challenges
- Opportunities
Increasing License Agreement among Key Market Players
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product launch/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario

4. Global Vaccine Technologies Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Global Vaccine Technologies Market, By Technology, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Live-attenuated vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Inactivated vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Subunit vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Toxoid vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Viral vector vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Messenger RNA (mRNA) vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

6. Global Vaccine Technologies Market, By Disease Indication, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Infectious Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Non-Infectious Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

7. Global Vaccine Technologies Market, By Route of Administration, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Parenteral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Nasal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

8. Global Vaccine Technologies Market, By Age Group, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Pediatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Adult
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

9. Global Vaccine Technologies Market, By Distribution Channel, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Public Sector
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Private Sector
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

10. Global Vaccine Technologies Market, By Region, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, By Country, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, For Country 2018 -2030
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution , 2018-2030, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 - 2030, (US$ Bn)
U.S.
Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 - 2030, (US$ Bn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 - 2030, (US$ Bn)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 - 2030, (US$ Bn)
Brazil
Mexico
Argentina
Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 - 2030, (US$ Bn)
GCC
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 - 2030, (US$ Bn)
North Africa
Central Africa
South Africa

11. Competitive Landscape

Pfizer-BioNTech
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Moderna
Johnson & Johnson
AstraZeneca
Sanofi
Novavax
GSK
Sinovac Biotech
Bharat Biotech
Emergent BioSolutions
Dynavax Technologies
CureVac
Valneva
Takeda Pharmaceutical Company Limited
Analyst Views

12. Section

Research Methodology
About us